Chris Timmermann obtained his PhD in 2020, working with Robin Carhart-Harris, Rob Leech and David Nutt in the Centre for Psychedelic Research at Imperial College London. He is currently a post-doc at Imperial College London at the Centre for Psychedelic Research, where he leads the DMT Research Group, studying the mechanisms of action of the potent psychedelics N,N-DMT and 5-MeO-DMT.

His empirical and theoretical work employs an interdisciplinary approach to the neuroscience, psychiatry, psychology, and ethics of psychedelics, their relationship to consciousness and applications in mental health. He focuses particularly on the brain mechanisms of psychedelics using fMRI, M/EEG, with a special focus on DMT and 5-MeO-DMT. He also researches the contribution of altered states, such as psychedelics and meditation, to the understanding of human consciousness, and the impact of psychedelics and meditation on mental health.

His work has been published in high-regarded scientific journals and covered by mass media outlets (BBC, CBC, Wired, The Times, New Scientist).